Cargando…
Health care use and costs of adverse drug events emerging from outpatient treatment in Germany: A modelling approach
BACKGROUND: This study's aim was to develop a first quantification of the frequency and costs of adverse drug events (ADEs) originating in ambulatory medical practice in Germany. METHODS: The frequencies and costs of ADEs were quantified for a base case, building on an existing cost-of-illness...
Autores principales: | Stark, Renee G, John, Jürgen, Leidl , Reiner |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3032652/ https://www.ncbi.nlm.nih.gov/pubmed/21232111 http://dx.doi.org/10.1186/1472-6963-11-9 |
Ejemplares similares
-
Cost‐effectiveness of increasing the reach of smoking cessation interventions in Germany: results from the EQUIPTMOD
por: Huber, Manuel B., et al.
Publicado: (2017) -
A pilot study on patient-related costs and factors associated with the cost of specialist palliative care in the hospital: first steps towards a patient classification system in Germany
por: Becker, Christian, et al.
Publicado: (2018) -
Preoperative patients’ health decrease moderately, while hospital costs increase for hip and knee replacement due to the first COVID-19 lockdown in Germany
por: Schatz, Caroline, et al.
Publicado: (2022) -
Association of Inappropriate Outpatient Pediatric Antibiotic Prescriptions With Adverse Drug Events and Health Care Expenditures
por: Butler, Anne M., et al.
Publicado: (2022) -
Development and first assessment of a questionnaire for health care utilization and costs for cardiac patients
por: Schweikert, Bernd, et al.
Publicado: (2008)